SILu™Prot AKT3 is a recombinant, stable isotope-labeled human AKT3 which incorporates [13C6, 15N4]-Arginine and [13C6, 15N2]-Lysine. Expressed in human 293 cells, it is designed to be used as an internal standard for bioanalysis of AKT3 in mass-spectrometry. SILu™Prot SOST is a protein of 500 amino acids (including N-terminal polyhistidine and flag tags), with a calculated molecular mass of 58.9 kDa.
Supplied as a liquid containing phosphate buffered saline.
This product is licensed under U.S. Patent No. 7,396,688 and foreign counterparts from E. I. du Pont de Nemours and Company. The purchase of this product conveys to the buyer the nontransferable right to use the purchased amount of the product for research and development only, including services for a third party for consideration. The buyer cannot sell or otherwise transfer this product, its components or materials made using this product or its components to a third party. Information about licenses for excluded uses is available from: E. I. du Pont de Nemours and Company; Attn: Associate Director, Commercial Development; DuPont Experimental Station E268; 200 Powdermill Rd.; Wilmington, DE 19803; 1-877-881-9787 (voice), 1-302-695-1437 (fax), firstname.lastname@example.org.
SILu is a trademark of Sigma-Aldrich Co. LLC